BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37653618)

  • 1. Nanoghosts: Harnessing Mesenchymal Stem Cell Membrane for Construction of Drug Delivery Platforms Via Optimized Biomimetics.
    Xiao Y; Xu RH; Dai Y
    Small; 2024 Jan; 20(1):e2304824. PubMed ID: 37653618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreating Mesenchymal Stem Cells with Cancer Conditioned-Media or Proinflammatory Cytokines Changes the Tumor and Immune Targeting by Nanoghosts Derived from these Cells.
    Lupu-Haber Y; Bronshtein T; Shalom-Luxenburg H; D'Atri D; Oieni J; Kaneti L; Shagan A; Hamias S; Amram L; Kaneti G; Cohen Anavy N; Machluf M
    Adv Healthc Mater; 2019 May; 8(10):e1801589. PubMed ID: 30963725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
    Shin MJ; Park JY; Lee DH; Khang D
    Int J Nanomedicine; 2021; 16():8485-8507. PubMed ID: 35002240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of mesenchymal stem cells in antineoplastic drugs delivery for tumor-targeted therapy].
    Wang X; Ouyang X; Sun X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):525-533. PubMed ID: 30693696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstructed stem cell nanoghosts: a natural tumor targeting platform.
    Toledano Furman NE; Lupu-Haber Y; Bronshtein T; Kaneti L; Letko N; Weinstein E; Baruch L; Machluf M
    Nano Lett; 2013 Jul; 13(7):3248-55. PubMed ID: 23786263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy.
    Fan L; Wei A; Gao Z; Mu X
    Biomed Pharmacother; 2023 May; 161():114451. PubMed ID: 36870279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers.
    Muslimov AR; Timin AS; Bichaykina VR; Peltek OO; Karpov TE; Dubavik A; Nominé A; Ghanbaja J; Sukhorukov GB; Zyuzin MV
    Biomater Sci; 2020 Feb; 8(4):1137-1147. PubMed ID: 31584052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
    Mohr A; Zwacka R
    Cancer Lett; 2018 Feb; 414():239-249. PubMed ID: 29175461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Membranes from Tumor-Tropic MSCs Screened by a Microfluidic Chip for Drug Nanoparticles Encapsulation and Cancer Targeted Therapy.
    Song Y; Shou X; Sheng B; Mei J; Shi K; Shang L; Zhu X
    Adv Healthc Mater; 2023 Jul; 12(17):e2202904. PubMed ID: 36815538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface Functionalization of Polymeric Nanoparticles with Umbilical Cord-Derived Mesenchymal Stem Cell Membrane for Tumor-Targeted Therapy.
    Yang N; Ding Y; Zhang Y; Wang B; Zhao X; Cheng K; Huang Y; Taleb M; Zhao J; Dong WF; Zhang L; Nie G
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22963-22973. PubMed ID: 29905067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Drug Delivery System Using Mesenchymal Stem Cells and Membrane-Coated Nanoparticles.
    Joshi S; Allabun S; Ojo S; Alqahtani MS; Shukla PK; Abbas M; Wechtaisong C; Almohiy HM
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-Engineered Mesenchymal Stem Cells Increase Therapeutic Efficacy of Anticancer Drug Through True Active Tumor Targeting.
    Layek B; Sadhukha T; Panyam J; Prabha S
    Mol Cancer Ther; 2018 Jun; 17(6):1196-1206. PubMed ID: 29592881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells.
    Timaner M; Letko-Khait N; Kotsofruk R; Benguigui M; Beyar-Katz O; Rachman-Tzemah C; Raviv Z; Bronshtein T; Machluf M; Shaked Y
    Cancer Res; 2018 Mar; 78(5):1253-1265. PubMed ID: 29301792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer.
    Weng Z; Zhang B; Wu C; Yu F; Han B; Li B; Li L
    J Hematol Oncol; 2021 Sep; 14(1):136. PubMed ID: 34479611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer.
    Yao S; Li X; Liu J; Sun Y; Wang Z; Jiang Y
    Drug Deliv; 2017 Nov; 24(1):1372-1383. PubMed ID: 28920712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic.
    Wu HH; Zhou Y; Tabata Y; Gao JQ
    J Control Release; 2019 Jan; 294():102-113. PubMed ID: 30553849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing knee joint resident mesenchymal stem cells in cartilage tissue engineering.
    Xu X; Xu L; Xia J; Wen C; Liang Y; Zhang Y
    Acta Biomater; 2023 Sep; 168():372-387. PubMed ID: 37481194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery.
    Wang M; Xin Y; Cao H; Li W; Hua Y; Webster TJ; Zhang C; Tang W; Liu Z
    Biomater Sci; 2021 Feb; 9(4):1088-1103. PubMed ID: 33332490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy.
    Huang X; Guo H; Wang L; Zhang Z; Zhang W
    Drug Discov Today; 2023 Apr; 28(4):103514. PubMed ID: 36736580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic Culture Strategies for the Clinical Expansion of Mesenchymal Stromal Cells.
    Wong KU; Zhang A; Akhavan B; Bilek MM; Yeo GC
    ACS Biomater Sci Eng; 2023 Jul; 9(7):3742-3759. PubMed ID: 33599471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.